Tezepelumab reduces and eliminates OCS use in OCS-dependent patients with severe asthma: Primary results from the Phase 3b WAYFINDER Study - Jackson, D J; Lugogo, N; Gurnell, M (Am J Respir Crit Care Med, 2025)